<?xml version="1.0" encoding="UTF-8"?>
<p>Extensive release of cytokines by the immune system in response to viral infection often results in sepsis symptoms, which caused mortality in 28% of COVID-19 cases [
 <xref rid="B3-molecules-25-05905" ref-type="bibr">3</xref>]. Sepsis is generally referred to as the dysregulated immune response to an infection that results in multiple organ dysfunction [
 <xref rid="B37-molecules-25-05905" ref-type="bibr">37</xref>]. The pathophysiology of sepsis-associated liver injury involves hypoxic liver injury due to several factors, including ischemia and shock, cholestasis, and overwhelming inflammation [
 <xref rid="B38-molecules-25-05905" ref-type="bibr">38</xref>]. It is observed that sepsis is not uncommon in patients with existing liver cirrhosis [
 <xref rid="B39-molecules-25-05905" ref-type="bibr">39</xref>], suggesting that pneumonia associated hypoxia is one of the most significant factors causing secondary liver injury in COVID-19 patients.
</p>
